 |
cultured, partially T-Cell depleted, allogenic thymic tissue for transplantation |
|---|---|
| Trade Name | |
| Orphan Indication | DiGeorge syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2003-08-15 00:00:00 |
| Sponsor | Enzyvant Therapeutics GmbH;Viaduktstrasse 8, CH-4051 Basel; |
Related Access Program